Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update
M Sun, X Zhang, B Tan, Q Zhang, X Zhao… - Frontiers in …, 2024 - frontiersin.org
As a chemotherapy agent, doxorubicin is used to combat cancer. However, cardiotoxicity
has limited its use. The existing strategies fail to eliminate doxorubicin-induced …
has limited its use. The existing strategies fail to eliminate doxorubicin-induced …
[HTML][HTML] Nuclear factor erythroid 2-related factor-mediated signaling alleviates ferroptosis during cerebral ischemia-reperfusion injury
Z Li, J Xing - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Cardiac arrest (CA) is a significant challenge for emergency physicians worldwide and leads
to increased morbidity and mortality rates. The poor prognosis of CA primarily stems from the …
to increased morbidity and mortality rates. The poor prognosis of CA primarily stems from the …
Prediction model of male reproductive function damage caused by CHOP chemotherapy regimen for non-Hodgkin's lymphoma
J Zhang, A Zhang, J Liu, X Xiao, Y Huang, W Zhou… - BMC cancer, 2024 - Springer
Objective The CHOP combined chemotherapy regimen (cyclophosphamide, doxorubicin,
vincristine, and prednisone) is commonly used to treat non-Hodgkin Lymphoma (NHL) …
vincristine, and prednisone) is commonly used to treat non-Hodgkin Lymphoma (NHL) …